drugset / Trial / NCT03663283

Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty

NCT03663283 ↗

Phase 4 Completed 104 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to determine if peripheral nerve block with liposomal bupivacaine in combination with standard bupivacaine will prolong the duration of block, improve pain scores, and decrease opioid utilization in the post-operative period when compared to peripheral nerve block with standard bupivacaine alone.

Timeline

Start
2018-10-29
Primary completion
2020-02-14
Completion
2020-02-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 25 ml Other
Comparator Bupivacaine Other / unclassified 133 mg Other

Indications